APA

Nebbioso A., Clarke N., Voltz E., Germain E., Ambrosino C., Bontempo P., Alvarez R., Schiavone E. M., Ferrara F., Bresciani F., Weisz A., de Lera A. R., Gronemeyer H. & Altucci L. (20050324). Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. : Nature medicine.

Chicago

Nebbioso Angela, Clarke Nicole, Voltz Emilie, Germain Emmanuelle, Ambrosino Concetta, Bontempo Paola, Alvarez Rosana, Schiavone Ettore M, Ferrara Felicetto, Bresciani Francesco, Weisz Alessandro, de Lera Angel R, Gronemeyer Hinrich and Altucci Lucia. 20050324. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. : Nature medicine.

Harvard

Nebbioso A., Clarke N., Voltz E., Germain E., Ambrosino C., Bontempo P., Alvarez R., Schiavone E. M., Ferrara F., Bresciani F., Weisz A., de Lera A. R., Gronemeyer H. and Altucci L. (20050324). Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. : Nature medicine.

MLA

Nebbioso Angela, Clarke Nicole, Voltz Emilie, Germain Emmanuelle, Ambrosino Concetta, Bontempo Paola, Alvarez Rosana, Schiavone Ettore M, Ferrara Felicetto, Bresciani Francesco, Weisz Alessandro, de Lera Angel R, Gronemeyer Hinrich and Altucci Lucia. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. : Nature medicine. 20050324.